Conflixis, a Dallas, Texas-based data and risk intelligence startup, has raised $4.2 million in seed funding.
Investors
The round was co-led by Lerer Hippeau and Origin Ventures, with participation from Mark VC, Springtime Ventures, and early backer Crētiv Capital.
Lerer Hippeau, a New York City-based early-stage venture capital firm, has backed over 350 startups since 2010, with investments across enterprise and consumer sectors.
Founded in 1999, Origin Ventures is an early-stage venture firm focusing on high-growth companies in the "Digital Native" economy, including software, hardware, and marketplace businesses.
Conflixis Use of Funds
The funding will support Conflixis in expanding its evidence-based influence models and predictive capabilities and growing its client-facing and R&D teams.
About Conflixis
Conflixis is a healthcare software platform addressing regulatory risk, waste, and overspending related to real and perceived conflicts of interest in healthcare. Leveraging advanced analytics and machine learning, Conflixis equips healthcare organizations with tools for informed decision-making and regulatory compliance in a complex and cost-sensitive environment.
Funding Details
Company: Conflixis, Inc.
Raised: $4.2M
Round: Seed Round
Funding Date: November 2024
Lead Investors: Lerer Hippeau, Origin Ventures
Additional Investors: Mark VC, Springtime Ventures, Crētiv Capital
Company Website: https://www.conflixis.com/
Software Category: Risk Management
Source: https://www.businesswire.com/news/home/20241108472886/en/